HMOX1 and acute myeloid leukemia: Furthermore, HO-1 protects AML cells from the apoptosis induced by proteasome inhibitor, bortezomib [99], or to front-line chemotherapeutic agents such as cytarabine and daunorubicin and HO-1 downregulation favors apoptosis [100].